DPP6 | Dipeptidyl-peptidase 6 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
DPP7 | Dipeptidyl-peptidase 7 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
DPP8 | Dipeptidyl-peptidase 8 | Enzymes Plasma proteins
| | | | | Expressed in all |
DPP9 | Dipeptidyl-peptidase 9 | Enzymes
| | | | | Expressed in all |
ECE1 | Endothelin converting enzyme 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ECE2 | Endothelin converting enzyme 2 | Enzymes Predicted membrane proteins
| | | | | Mixed |
ELANE | Elastase, neutrophil expressed | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | CD markers Enzymes Plasma proteins
| | | | | Group enriched |
EPHX1 | Epoxide hydrolase 1, microsomal (xenobiotic) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ERAP1 | Endoplasmic reticulum aminopeptidase 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ERAP2 | Endoplasmic reticulum aminopeptidase 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ERMP1 | Endoplasmic reticulum metallopeptidase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ESPL1 | Extra spindle pole bodies homolog 1 (S. cerevisiae) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
F12 | Coagulation factor XII (Hageman factor) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
F7 | Coagulation factor VII (serum prothrombin conversion accelerator) | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FAM105A | Family with sequence similarity 105, member A | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
FAM105B | Family with sequence similarity 105, member B | Enzymes
| | | | | Expressed in all |
FAP | Fibroblast activation protein, alpha | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FOLH1 | Folate hydrolase (prostate-specific membrane antigen) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FURIN | Furin (paired basic amino acid cleaving enzyme) | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
GGH | Gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GZMA | Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GZMH | Granzyme H (cathepsin G-like 2, protein h-CCPX) | Enzymes Predicted secreted proteins
| | | | | Mixed |
GZMM | Granzyme M (lymphocyte met-ase 1) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HABP2 | Hyaluronan binding protein 2 | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
HGF | Hepatocyte growth factor (hepapoietin A; scatter factor) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
HGFAC | HGF activator | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
HM13 | Histocompatibility (minor) 13 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HP | Haptoglobin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
HPN | Hepsin | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
HPR | Haptoglobin-related protein | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
HTRA1 | HtrA serine peptidase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
HTRA2 | HtrA serine peptidase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
HTRA3 | HtrA serine peptidase 3 | Enzymes Predicted secreted proteins
| | | | | Mixed |
HTRA4 | HtrA serine peptidase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
IDE | Insulin-degrading enzyme | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
IMMP1L | IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae) | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
IMMP2L | IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
KEL | Kell blood group, metallo-endopeptidase | Blood group antigen proteins Cancer-related genes CD markers Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
KLK10 | Kallikrein-related peptidase 10 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KLK11 | Kallikrein-related peptidase 11 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KLK12 | Kallikrein-related peptidase 12 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KLK13 | Kallikrein-related peptidase 13 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
KLK14 | Kallikrein-related peptidase 14 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK15 | Kallikrein-related peptidase 15 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KLK2 | Kallikrein-related peptidase 2 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK3 | Kallikrein-related peptidase 3 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK4 | Kallikrein-related peptidase 4 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |